The Current Landscape of Transcatheter Tricuspid Valve Intervention - PubMed (original) (raw)

Review

The Current Landscape of Transcatheter Tricuspid Valve Intervention

Henry Seligman et al. J Soc Cardiovasc Angiogr Interv. 2023.

Abstract

Tricuspid regurgitation (TR) is common, and its prevalence increases with age. It was previously estimated that there are 1.6 million patients in the United States with moderate or worse TR, and more contemporary data suggest the age-adjusted prevalence of TR is 0.55%. Increasing TR severity is associated with an adverse prognosis independent of the pulmonary artery pressure and the degree of right heart failure. In heart failure with reduced ejection fraction, survival is significantly worsened when moderate or severe TR is present. The mainstay of therapy has traditionally been surgery, but outcomes are poor. There has been increasing attention on the potential role of transcatheter interventions for TR. Numerous platforms are in developmental evolution, which broadly fall into 3 categories: valve replacement, valve repair (subdivided into annular, leaflet, and chordal platforms), and caval valve implantation. In this review, we examine all these strategies and devices, including guidance on how to appropriately select patients who can benefit from intervention.

Keywords: transcatheter valve intervention; tricuspid regurgitation; valve repair; valve replacement.

© 2023 Published by Elsevier Inc. on behalf of the Society for Cardiovascular Angiography and Interventions Foundation.

PubMed Disclaimer

Conflict of interest statement

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

None

Graphical abstract

Central illustration

Central illustration

A summary of the models and types of device currently available for transcatheter treatment of severe tricuspid regurgitation.

Figure 1

Figure 1

A step-wise approach to assessment and device selection in patients with severe tricuspid regurgitation. RV, right ventricular; TR, tricuspid regurgitation; TV, tricuspid valve.

References

    1. Topilsky Y., Maltais S., Medina Inojosa J., et al. Burden of tricuspid regurgitation in patients diagnosed in the community setting. J Am Coll Cardiol Cardiovasc Img. 2019;12(3):433–442. -PubMed
    1. McCarthy P.M., Sales V.L. Evolving indications for tricuspid valve surgery. Curr Treat Options Cardiovasc Med. 2010;12(6):587–597. -PMC -PubMed
    1. Chorin E., Rozenbaum Z., Topilsky Y., et al. Tricuspid regurgitation and long-term clinical outcomes. Eur Heart J Cardiovasc Imaging. 2020;21(2):157–165. -PubMed
    1. Nath J., Foster E., Heidenreich P.A. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004;43(3):405–409. -PubMed
    1. Wang N., Fulcher J., Abeysuriya N., et al. Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis. Eur Heart J. 2019;40(5):476–484. -PubMed

Publication types

LinkOut - more resources